We are looking for 2–17 year olds to join a CD trial to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or moderate to severe ulcerative colitis (including associated symptoms such as rectal pain, mouth sores, abdominal pain, frequent fevers and/or canker sores), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years old may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child qualifies.
